The effects of growth hormone on therapy resistance in cancer

Abstract

Pituitary derived and peripherally produced growth hormone (GH) is a crucial mediator of longitudinal growth, organ development, metabolic regulation with tissue specific, sex specific, and age-dependent effects. GH and its cognate receptor (GHR) are expressed in several forms of cancer and have been validated as an anti-cancer target through a large body of in vitro, in vivo and epidemiological analyses. However, the underlying molecular mechanisms of GH action in cancer prognosis and therapeutic response had been sparse until recently. This review assimilates the critical details of GH-GHR mediated therapy resistance across different cancer types, distilling the therapeutic implications based on our current understanding of these effects.

Keywords

Growth hormone receptor / growth hormone / therapy resistance / chemoresistance

References

[1] Peters GJ.Cancer drug resistance: a new perspective..Cancer Drug Resist2018;1:1-5

[2] Basu R,Kopchick JJ.Mechanisms in endocrinology: lessons from growth hormone receptor gene disrupted mice: are there benefits of endocrine defects?.Eur J Endocrinol2018;178:R155-81

[3] Kopchick JJ,Kelder B,Berryman DE.Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications..Mol Cell Endocrinol2014;386:34-45 PMCID:PMC3943600

[4] Lu M,Langley RJ,Perry JK.Targeting growth hormone function: strategies and therapeutic applications..Signal Transduct Target Ther2019;4:3 PMCID:PMC6367471

[5] Young JA, List EO, Kopchick JJ. Deconstructing the growth hormone receptor(GHR): physical and metabolic phenotypes of tissue-specific GHR gene-disrupted mice. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1877117315002161. [Last accessed on 19 Jun 2019]

[6] Pombo M,Garcia A,Gualillo O.Hormonal control of growth hormone secretion..Horm Res.2001;55 Suppl 1:11-6

[7] Khatib N,Gaidhane AM,Simkhada P.Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion..J Clin Diagn Res2014;8:MC13-7 PMCID:PMC4190751

[8] Dimaraki EV.Role of endogenous ghrelin in growth hormone secretion, appetite regulation and metabolism..Rev Endocr Metab Disord2006;7:237-49

[9] Müller EE.Brain catecholamines and growth hormone release. Aspects of Neuroendocrinology.1970;Berlin, HeidelbergSpringer Berlin Heidelberg206-19

[10] Buonomo FC,Lauterio TJ.Catecholamine involvement in the control of growth hormone secretion in the domestic fowl..Gen Comp Endocrinol.1984;54:360-71

[11] Chang JP,Cook AF,Peter RE.Influences of catecholamines on growth hormone release in female goldfish, Carassius auratus..Neuroendocrinology1985;40:463-70

[12] Pritzlaff CJ,Blumer J,Abbott RD.Catecholamine release, growth hormone secretion, and energy expenditure during exercise vs. recovery in men..J Appl Physiol2000;89:937-46

[13] Brooks AJ.The growth hormone receptor: mechanism of activation and clinical implications..Nat Rev Endocrinol2010;6:515-25

[14] Waters MJ.JAK2 activation by growth hormone and other cytokines..Biochem J2015;466:1-11 PMCID:PMC4325515

[15] Rowland JE,Kerr LM,D’Aniello EM.In vivo analysis of growth hormone receptor signaling domains and their associated transcripts..Mol Cell Biol2005;25:66-77 PMCID:PMC538772

[16] Carter-Su C,Argetsinger LS,Vanderkuur J.Signalling pathway of GH..Endocr J1996;43:S65-70

[17] Jin H,Carter-Su C.JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells..Mol Endocrinol2008;22:1825-41 PMCID:PMC2505331

[18] Bocharov EV,Bocharova OV,Pavlov KV.Structural basis of the signal transduction via transmembrane domain of the human growth hormone receptor..Biochim Biophys acta Gen Subj2018;1862:1410-20

[19] Zhu T,Graichen R,Lobie PE.Signal transduction via the growth hormone receptor..Cell Signal2001;13:599-616

[20] Keene DE,Bostwick MG,Bartke A.Puberty is delayed in male growth hormone receptor gene-disrupted mice..J Androl2015;23:661-8

[21] Bougnères PF.Growth hormone effects on carbohydrate and lipid metabolism in childhood..Horm Res1993;40:31-3

[22] DAVIDSON MB.Effect of growth hormone on carbohydrate and lipid metabolism..Endocr Rev1987;8:115-31

[23] Møller N.Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects..Endocr Rev2009;30:152-77

[24] Vijayakumar A,Wu Y,LeRoith D.Biological effects of growth hormone on carbohydrate and lipid metabolism..Growth Horm IGF Res2010;20:1-7 PMCID:PMC2815161

[25] Duran-Ortiz S,Kopchick JJ.Growth hormone impact on adipose tissue and aging..Curr Opin Endocr Metab Res2019;5:45-57

[26] Berryman D.Growth Hormone’s effect on adipose tissue: quality versus quantity..Int J Mol Sci2017;18:1621 PMCID:PMC5578013

[27] Duran-Ortiz S,Kopchick JJ.The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies..Clin Proteomics2017;14:24 PMCID:PMC5492507

[28] Bartke A.Pleiotropic effects of growth hormone signaling in aging..Trends Endocrinol Metab2011;22:437-42 PMCID:PMC4337825

[29] Ashpole NM,Yabluchanskiy A,Yan H.IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan..GeroScience2017;39:129-45 PMCID:PMC5411370

[30] Sonntag WE,Cefalu WT,Bennett SA.Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals..J Gerontol A Biol Sci Med Sci1999;54:B521-38

[31] Basu A,Kopchick JJ.Spatial learning and memory in male mice with altered growth hormone action..Horm Behav2017;93:18-30

[32] Gosney ES,Basu A.GH in the central nervous system: lessons from the growth hormone receptor knockout mouse..2012;6:34-41

[33] Guevara-Aguirre J,Balasubramanian P,Guevara-Aguirre M.GH receptor deficiency in ecuadorian adults is associated with obesity and enhanced insulin sensitivity..J Clin Endocrinol Metab2015;100:2589-96 PMCID:PMC4490304

[34] Laron Z.Lessons from 50 years of study of Laron syndrome..Endocr Pract2015;21:1395-402

[35] Treadway MT.Reconsidering anhedonia in depression: lessons from translational neuroscience..Neurosci Biobehav Rev2011;35:537-55 PMCID:PMC3005986

[36] Savage MO,Rosenfeld RG.The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges..Clin Endocrinol (Oxf)2009;72:721-8

[37] Laron Z.Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003..J Clin Endocrinol Metab2004;89:1031-44

[38] Ginsberg S,Bed MA.The obesity of patients with Laron syndrome is not associated with excessive nutritional intake..Obes Res Clin Pract2009;3:3-8

[39] Guevara-Aguirre J,Guevara C,Rosado V.Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives..Growth Horm IGF Res2016;28:76-8

[40] Guevara-Aguirre J,Fielder PJ,Rosenfeld RG.Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations..J Clin Endocrinol Metab1993;76:417-23

[41] Junnila RK,Suer O,Berryman DE.Disruption of the GH receptor gene in adult mice increases maximal lifespan in females..Endocrinology2016;157:4502-13

[42] Junnila RK,Berryman DE,Kopchick JJ.The GH/IGF-1 axis in ageing and longevity..Nat Rev Endocrinol2013;9:366-76 PMCID:PMC4074016

[43] Krzisnik C,Battelino T,Parks JS.The “Little People” of the Island of Krk - revisited. Etiology of Hypopituitarism Revealed..Int J Disabil Hum Dev1999;1:

[44] Krzisnik C,Cvijović K.Longevity of the hypopituitary patients from the island Krk: a follow-up study..Pediatr Endocrinol Rev2010;7:357-62

[45] Salvatori R,Aguiar-Oliveira MH,Souza AHO.Familial Dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene 1..J Clin Endocrinol Metab1999;84:917-23

[46] Costa UMM,Salvatori R,Campos VC.Brazilian adult individuals with untreated isolated GH deficiency do not have accelerated subclinical atherosclerosis..Endocr Connect2016;5:41-6 PMCID:PMC4738236

[47] Baumann G.The dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene..Acta Paediatr Suppl1997;423:33-8

[48] Besson A,Gallati S,Horn R.Reduced longevity in untreated patients with isolated growth hormone deficiency..J Clin Endocrinol Metab2003;88:3664-7

[49] Rozzi FVR,Froment A,Botton J.Growth pattern from birth to adulthood in African pygmies of known age..Nat Commun2015;6:7672 PMCID:PMC4525207

[50] Melmed S.Acromegaly pathogenesis and treatment..J Clin Invest2009;119:3189-202 PMCID:PMC2769196

[51] Adelman D,Nachtigall,Bakker B.Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment..Int J Gen Med2013;31: PMCID:PMC3555549

[52] Dal J,Hermansen K,Bengtsen M.Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature..J Clin Endocrinol Metab2018;103:2182-8

[53] Wolinski K,Dyrda K,Pelka M.Risk of malignant neoplasms in acromegaly: a case-control study..J Endocrinol Invest2017;40:319-22 PMCID:PMC5331105

[54] Ruchała M,Fularz M.Risk of neoplasms in acromegaly..Contemp Oncol (Poznan, Poland)2012;16:111-7 PMCID:PMC3687397

[55] Wolinski K,Ruchala M.Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly - meta-analysis and systematic review..PLoS One2014;9:e88787 PMCID:PMC3925168

[56] Cummings EA,Dekker MG,Daneman D.Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes..Diabetes1998;47:1341-6

[57] Landau D,Rivkis I,Schrijvers BF.The effect of growth hormone on the development of diabetic kidney disease in rats..Nephrol Dial Transplant2003;18:694-702

[58] Kumar PA,Menon RK.The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy..Curr Diabetes Rev2011;7:50-5 PMCID:PMC4007067

[59] Dekkers OM,Pereira AM,Vandenbroucke JP.Mortality in acromegaly: a metaanalysis..J Clin Endocrinol Metab2008;93:61-7

[60] Ratajczak MZ,Darzynkiewicz Z.Prolonged growth hormone/insulin/insulin-like growth factor nutrient response signaling pathway as a silent killer of stem cells and a culprit in aging..Stem Cell Rev Reports2017;13:443-53 PMCID:PMC5493720

[61] Palmer AJ,List EO,Okada S.Age-related changes in body composition of bovine growth hormone transgenic mice..Endocrinology2009;150:1353-60 PMCID:PMC2654748

[62] Kucia M,Liu R,Ratajczak J.The negative effect of prolonged somatotrophic/insulin signaling on an adult bone marrow-residing population of pluripotent very small embryonic-like stem cells (VSELs)..Age (Omaha)2013;35:315-30 PMCID:PMC3592960

[63] Janecka A,Biesaga B.Clinical and molecular features of laron syndrome, a genetic disorder protecting from cancer..In Vivo2016;30:375-81

[64] Di Bella G,Scanferlato R.The over-expression of GH/GHR in tumour tissues with respect to healthy ones confirms its oncogenic role and the consequent oncosuppressor role of its physiological inhibitor, somatostatin: a review of the literature..Neuro Endocrinol Lett2018;39:179-88

[65] Brittain AL,Qian Y.Growth hormone and the epithelial-to-mesenchymal transition..J Clin Endocrinol Metab2017;102:3662-73

[66] Kong X,Yuan Y,Wu Z.Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma..Oncotarget2016;7:29465-79 PMCID:PMC5045410

[67] Chhabra Y,Brooks AJ.Role of the growth hormone-IGF-1 axis in cancer..Expert Rev Endocrinol Metab2011;6:71-84

[68] Perry JK,Wu ZS,Lobie PE.Growth hormone and cancer: an update on progress..Curr Opin Endocrinol Diabetes Obes2013;20:307-13

[69] Boguszewski CL.Growth Hormone’s links to cancer..Endocr Rev2019;40:558-74

[70] Boguszewski CL.Update on GH therapy in adults..F1000Research2017;6:2017 PMCID:PMC5691372

[71] Poidvin A,Ecosse E,Michon J.Increased risk of bone tumors after growth hormone treatment in childhood: a population-based cohort study in France..Cancer Med2018; PMCID:PMC6051149

[72] Swerdlow AJ,Beckers D,Carel JC.Risk of meningioma in european patients treated with growth hormone in childhood: results from the SAGhE cohort..J Clin Endocrinol Metab2019;104:658-64 PMCID:PMC6334265

[73] Swerdlow AJ,Beckers D,Butler G.Cancer risks in patients treated with growth hormone in childhood: the SAGhE European cohort study..J Clin Endocrinol Metab2017;102:1661-72 PMCID:PMC6061931

[74] Jørgensen JOL.Therapy of endocrine disease: growth hormone replacement therapy in adults: 30 years of personal clinical experience..Eur J Endocrinol2018;179:R47-56

[75] Höybye C.Growth hormone replacement in adults - current standards and new perspectives..Best Pract Res Clin Endocrinol Metab2015;29:115-23

[76] Quigley CA,Zimmermann AG,Robison LL.Mortality in children receiving growth hormone treatment of growth disorders: data from the genetics and neuroendocrinology of short stature international study..J Clin Endocrinol Metab2017;102:3195-205

[77] Child CJ,Chrousos GP,Deal CL.Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program..J Clin Endocrinol Metab2019;104:379-89 PMCID:PMC6300411

[78] Terzolo M,Berchialla P,Malchiodi E.Acromegaly is associated with increased cancer risk: a survey in Italy..Endocr Relat Cancer2017;24:495-504

[79] Rudd MF.Variants in the GH-IGF axis confer susceptibilityto lung cancer..Genome Res2006;16:693-701 PMCID:PMC1473180

[80] Chhabra Y,Nikolajsen LF,Papadopulos A.A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation..Oncogene2018;37:489-501 PMCID:PMC5799715

[81] Cao G,Feng J,Zheng D.Lung cancer risk associated with Thr495Pro polymorphism of GHR in Chinese population..Jpn J Clin Oncol2008;38:308-16

[82] Sobrier ML,Duquesnoy P,Yordam N.Nine novel growth hormone receptor gene mutations in patients with laron syndrome..J Clin Endocrinol Metab1997;82:435-7

[83] Laron Z,Lapkina L.IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome..Mutat Res Mutat Res2017;772:123-33

[84] Lapkina-Gendler L,Pasmanik-Chor M,Sarfstein R.Identification of signaling pathways associated with cancer protection in Laron syndrome..Endocr Relat Cancer2016;23:399-410

[85] Steuerman R,Laron Z.Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies..Eur J Endocrinol2011;164:485-9

[86] Pollak M,Zhang J.Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist..Br J Cancer2001;85:428-30 PMCID:PMC2364076

[87] Brunet-Dunand SE,Araneda S,Vidal LJP.Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma..Endocrinology2009;150:1341-52

[88] Perry JK,Mertani HC,Lobie PE.Tumour-derived human growth hormone as a therapeutic target in oncology..Trends Endocrinol Metab2017;28:587-96

[89] Weroha SJ.The insulin-like growth factor system in cancer..Endocrinol Metab Clin North Am2012;41:335-50vi PMCID:PMC3614012

[90] Yuan J,Tao K,Gao J.Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy..Oncol Lett2018;15:41-7 PMCID:PMC5738696

[91] Kawa MP,Piecyk K,Rogińska D.The impact of growth hormone therapy on the apoptosis assessment in CD34+ hematopoietic cells from children with growth hormone deficiency..Int J Mol Sci2017;18: PMCID:PMC5297745

[92] Kastan MB,Leonard CJ.P53, cell cycle control and apoptosis: implications for cancer..Cancer Metastasis Rev1995;14:3-15

[93] Chen J.The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression..Cold Spring Harb Perspect Med2016;6:a026104 PMCID:PMC4772082

[94] van Oijen MG.Gain-of-function mutations in the tumor suppressor gene p53..Clin Cancer Res2000;6:2138-45

[95] Arnold RE.The inhibition of apoptosis in EL4 lymphoma cells overexpressing growth hormone..Neuroimmunomodulation2004;11:149-59

[96] Chesnokova V,Zhou C,Ben-Shlomo A.Growth hormone is permissive for neoplastic colon growth..Proc Natl Acad Sci U S A2016;113:E3250-9 PMCID:PMC4988562

[97] Chesnokova V,Barrett R,Wawrowsky K.Excess growth hormone suppresses DNA damage repair in epithelial cells..JCI insight2019;4: PMCID:PMC6413789

[98] Chesnokova V,Ben-Shlomo A,Tani Y.Growth hormone is a cellular senescence target in pituitary and nonpituitary cells..Proc Natl Acad Sci U S A2013;110:E3331-9 PMCID:PMC3761588

[99] Waters MJ.The oncogenic potential of autocrine human growth hormone in breast cancer..Proc Natl Acad Sci U S A2004;101:14992-3 PMCID:PMC524049

[100] Conway-Campbell BL,Brooks AJ,Brown RJ.Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis..Proc Natl Acad Sci U S A2007;104:13331-6 PMCID:PMC1948913

[101] Cheng Q.Mechanism of p53 stabilization by ATM after DNA damage..Cell Cycle2010;9:472-8 PMCID:PMC2977994

[102] Podlutsky A,Yancey K,Nagykaldi E.The GH/IGF-1 axis in a critical period early in life determines cellular DNA repair capacity by altering transcriptional regulation of DNA repair-related genes: implications for the developmental origins of cancer..GeroScience2017;39:147-60 PMCID:PMC5411369

[103] Minoia M,Molè D,Filieri C.Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression..J Clin Endocrinol Metab2012;97:E907-16

[104] Zatelli MC,Molè D,Tagliati F.Growth hormone excess promotes breast cancer chemoresistance..J Clin Endocrinol Metab2009;94:3931-8

[105] Gentilin E,Bondanelli M,Degli Uberti EC.Growth hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines..Endocrine2017;56:621-32

[106] Bogazzi F,Raggi F,Vanacore R.Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-γ ligands..Endocrinology2004;145:3353-62

[107] Subramani R,Salcido A,Arumugam A.Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma..Exp Mol Med2014;46:e117 PMCID:PMC4221692

[108] Subramani R,Pedroza DA.Role of growth hormone in breast cancer..Endocrinology2017;158:1543-55

[109] Kaulsay KK,Törnell J,Lee KO.Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone..Exp Cell Res1999;250:35-50

[110] Mertani HC,Goh EL,Morel G.Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival..J Biol Chem2001;276:21464-75

[111] Kalluri R.The basics of epithelial-mesenchymal transition..J Clin Invest2009;119:1420-8 PMCID:PMC2689101

[112] Lamouille S,Derynck R.Molecular mechanisms of epithelial-mesenchymal transition..Nat Rev Mol Cell Biol2014;15:178-96 PMCID:PMC4240281

[113] Singh A.EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer..Oncogene2010;29:4741-51 PMCID:PMC3176718

[114] Du B.Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer..Molecules2016;21:965 PMCID:PMC6273543

[115] Tsai JH.Epithelial-mesenchymal plasticity in carcinoma metastasis..Genes Dev2013;27:2192-206 PMCID:PMC3814640

[116] Mitra A,Li S.EMT, CTCs and CSCs in tumor relapse and drug-resistance..Oncotarget2015;6:10697-711 PMCID:PMC4484413

[117] Kong D,Wang Z.Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?.Cancers (Basel)2011;3:716-29 PMCID:PMC3106306

[118] Aiello NM,Kang Y,Weinberg RA.Upholding a role for EMT in pancreatic cancer metastasis..Nature2017;547:E7-8 PMCID:PMC5830071

[119] Fischer KR,Lee S,Li F.Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance..Nature2015;527:472-6 PMCID:PMC4662610

[120] Kurrey NK,Joglekar AV,Chaskar PD.Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells..Stem Cells2009;27:2059-68

[121] Yang H,Che X.Slug inhibition increases radiosensitivity of nasopharyngeal carcinoma cell line C666-1..Exp Ther Med2018;15:3477-82 PMCID:PMC5840900

[122] Pulkka OP,Sarlomo-Rikala M,Eriksson M.SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour..Br J Cancer2017;116:1195-202 PMCID:PMC5418455

[123] Yochum ZA,Burns TF.Paradoxical functions of ZEB1 in EGFR-mutant lung cancer: tumor suppressor and driver of therapeutic resistance..J Thorac Dis2016;8:E1528-31 PMCID:PMC5179406

[124] Yochum ZA,Wang H,Simons BW.Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer..Oncogene2019;38:656-70 PMCID:PMC6358506

[125] Mukhina S,Guo K,Gluckman PD.Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone..Proc Natl Acad Sci U S A2004;101:15166-71 PMCID:PMC524067

[126] Yilmaz M.EMT, the cytoskeleton, and cancer cell invasion..Cancer Metastasis Rev2009;28:15-33

[127] Aiello NM,Norgard RJ,Li J.EMT subtype influences epithelial plasticity and mode of cell migration..Dev Cell2018;45:681-95.e4 PMCID:PMC6014628

[128] Zhang X,Chen Y,Lee KO.Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene..J Biol Chem2003;278:7580-90

[129] Zhu T,Zhang X,Gluckman PD.Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone..Cancer Res2005;65:317-24

[130] Shafiei F,Pawella L,Gluckman PD.DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells..Oncogene2008;27:2602-12

[131] Wang JJ,Sun XB,Pandey V.Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma..Oncotarget2017;8: PMCID:PMC5732775

[132] Basu R,Kopchick J.Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways..Oncotarget2017;5: PMCID:PMC5400608

[133] Pandey V,Mohankumar KM,Liu SM.Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells..Endocrinology2008;149:3909-19 PMCID:PMC2488240

[134] Chen Z,Zhang L,Deng M.Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade..Cancer Lett2016;370:153-64

[135] Montanari F.Prediction of drug-ABC-transporter interaction - recent advances and future challenges..Adv Drug Deliv Rev2015;86:17-26 PMCID:PMC6422311

[136] Heimerl S,Langmann T,Schmitz G.Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells..Melanoma Res2007;17:265-73

[137] Robey RW,Hall MD,Bates SE.Revisiting the role of ABC transporters in multidrug-resistant cancer..Nat Rev Cancer2018;18:452-64

[138] Kathawala RJ,Ashby CR.The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade..Drug Resist Updat2015;18:1-17

[139] Szakács G,Lababidi S,Arciello A.Predicting drug sensitivity and resistance..Cancer Cell2004;6:129-37

[140] Dvorak P,Soucek P.ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer..Tumor Biol2017;39:101042831769980

[141] Choi CH.ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal..Cancer Cell Int2005;5:30 PMCID:PMC1277830

[142] Ejendal KFK.Multidrug resistance and cancer: the role of the human ABC transporter ABCG2..Curr Protein Pept Sci2002;3:503-11

[143] Jaramillo AC,Cloos J,Peters GJ.How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?.Cancer Drug Resist2018;1:6-29

[144] Chen KG,Gillet JP,Gottesman MM.Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma..Pigment Cell Melanoma Res2009;22:740-9 PMCID:PMC2766009

[145] Chen KG,Lai B,Paterson JK.Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas..Proc Natl Acad Sci2006;103:9903-7 PMCID:PMC1502551

[146] Bougen NM,Chen H,Perry JK.Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C..Oncol Rep2011;26:487-93

[147] Holtz AN,Beckwith H.Abstract 5839: growth hormone receptor (GHR) expression confers resistance to ruxolitinib in endocrine-resistant breast cancer cells..Cancer Res2018;78:5839

[148] Basu R,Wu S.Growth hormone receptor knockdown sensitizes human melanoma cells to chemotherapy by attenuating expression of ABC drug efflux pumps..Horm Cancer2017;8:143-56

[149] Arumugam A,Nandy SB,Dwivedi AK.Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2..Exp Mol Med2019;51:2 PMCID:PMC6323053

[150] Wu AML,Lu X,Riddick DS.Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells..Mol Pharmacol2013;83:377-88

[151] Santisteban M.ABC transporters as molecular effectors of pancreatic oncogenic pathways: the hedgehog-GLI model..J Gastrointest Cancer2010;41:153-8

[152] Fletcher JI,Henderson MJ.ABC transporters in cancer: more than just drug efflux pumps..Nat Rev Cancer2010;10:147-56

[153] Pahnke J,Krohn M.Alzheimer’s and ABC transporters - new opportunities for diagnostics and treatment..Neurobiol Dis2014;72:54-60 PMCID:PMC4199932

[154] Abuznait AH.Role of ABC transporters in the pathogenesis of Alzheimer’s disease..ACS Chem Neurosci2012;3:820-31 PMCID:PMC3504479

[155] Mahringer A.ABC transporters at the blood-brain barrier..Expert Opin Drug Metab Toxicol2016;12:499-508

[156] Tarling EJ,Edwards PA.Role of ABC transporters in lipid transport and human disease..Trends Endocrinol Metab2013;24:342-50 PMCID:PMC3659191

[157] Schumacher T.ABC transport proteins in cardiovascular disease-a brief summary..Molecules2017;22: PMCID:PMC6154303

[158] Gottesman MM.Overview: ABC transporters and human disease..J Bioenerg Biomembr2001;33:453-8

[159] Stanton B.ABC transporters in liver, kidney, and intestine..Kidney Int2002;62:1520-1

[160] Stefková J,Hubácek JA.ATP-binding cassette (ABC) transporters in human metabolism and diseases..Physiol Res2004;53:235-43

[161] Batlle E.Cancer stem cells revisited..Nat Med2017;23:1124-34

[162] Ciurea ME,Purcaru SO,Emami GH.Cancer stem cells: biological functions and therapeutically targeting..Int J Mol Sci2014;15:8169-85 PMCID:PMC4057726

[163] Phi LTH,Yang YG,Jun N.Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment..Stem Cells Int2018;2018:1-16 PMCID:PMC5850899

[164] Florea V,Kanashiro-Takeuchi RM,Block NL.Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival..Proc Natl Acad Sci2014;111:17260-5 PMCID:PMC4260571

[165] Sackmann-Sala L,Goffin V.Minireview: prolactin regulation of adult stem cells..Mol Endocrinol2015;29:667-81 PMCID:PMC5414739

[166] Sackmann-Sala L.Prolactin-induced prostate tumorigenesis..Adv Exp Med Biol2015;846:221-42

[167] Neradugomma NK,Tawfik OW,Kumar TR.Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner..Carcinogenesis2014;35:795-806 PMCID:PMC3977144

[168] Chen YJ,Wu ZS,Lau AYC.Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells..Cancer Lett2015;365:182-9

[169] Lombardi S,Ginestier C,Marlow R.Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells..Stem Cell Reports2014;2:780-93 PMCID:PMC4050343

[170] Chen YJ,Chong QY,Zhuang QS.Autocrine human growth hormone promotes invasive and cancer stem cell-like behavior of hepatocellular carcinoma cells by STAT3 dependent inhibition of CLAUDIN-1 expression..Int J Mol Sci2017;18:1274 PMCID:PMC5486096

[171] Chen HHW.Improving radiotherapy in cancer treatment: Promises and challenges..Oncotarget2017;8:62742-58 PMCID:PMC5617545

[172] Baskar R,Yeo R.Cancer and radiation therapy: current advances and future directions..Int J Med Sci2012;9:193-9 PMCID:PMC3298009

[173] Kim BM,Lee S,Lim JH.Therapeutic implications for overcoming radiation resistance in cancer therapy..Int J Mol Sci2015;16:26880-913 PMCID:PMC4661850

[174] Barker HE,Khan AA.The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence..Nat Rev Cancer2015;15:409-25 PMCID:PMC4896389

[175] Willers H,Santivasi WL.Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer..Cancer J2013;19:200-7 PMCID:PMC3668666

[176] Redelman D,Taub D.Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network..Cell Immunol252:111-21 PMCID:PMC4777337

[177] Bougen NM,Pertziger M,Brunet-Dunand SE.Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells..Endocr Relat Cancer2012;19:625-44

[178] Prieto I,García Grande A,Carralero I.Morphometric and proliferative effects of growth hormone on radiation enteritis in the rat..Rev Esp Enferm Dig1998;90:163-73

[179] Lempereur L,Maria Scoto G,Goffin V.Growth hormone protects human lymphocytes from irradiation-induced cell death..Br J Pharmacol2003;138:1411-6 PMCID:PMC1573792

[180] Morante J,Gómez-García L,Gómez-de-Segura IA.Differential action of growth hormone in irradiated tumoral and nontumoral intestinal tissue..Dig Dis Sci2003;48:2159-66

[181] Caz V,Tabernero M,Lopez-Plaza B.Growth hormone protects the intestine preserving radiotherapy efficacy on tumors: a short-term study..PLoS One2015;10:e0144537 PMCID:PMC4682900

[182] Chen BJ,Spasojevic I,Jiang C.Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates..PLoS One2010;5:e11056 PMCID:PMC2886847

[183] Zhou D,Kang Y,Li Z.Insulin-like growth factor 1 mitigates hematopoietic toxicity after lethal total body irradiation..Int J Radiat Oncol Biol Phys2013;85:1141-8 PMCID:PMC3562560

[184] Wu XY,Yao XQ,Xu Z.Growth hormone protects colorectal cancer cells from radiation by improving the ability of DNA damage repair..Mol Med Rep2014;10:486-90

[185] Evans A,Liu DX,Perry JK.Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model..Cancer Lett2016;379:117-23

[186] Wu X,Li G,Chen C.Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy..Eur J Cancer2006;42:888-94

[187] Bonnans C,Werb Z.Remodelling the extracellular matrix in development and disease..Nat Rev Mol Cell Biol2014;15:786-801 PMCID:PMC4316204

[188] Burnier J V,Michel RP,Li S.Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis..Oncogene2011;30:3766-83

[189] Jenkins MH,Mullins DW.The BRAFV600E inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells..Matrix Biol2015;48:66-77 PMCID:PMC5048745

[190] Fang M,Peng C.Collagen as a double-edged sword in tumor progression..Tumor Biol2014;35:2871-82 PMCID:PMC3980040

[191] Rizwan A,Kalaichelvan A,Krishnamachary B.Metastatic breast cancer cells in lymph nodes increase nodal collagen density..Sci Rep2015;5:10002 PMCID:PMC4423440

[192] Gao H,Zhang Z,Gadiya M.Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling..Cell2016;166:47-62 PMCID:PMC4980842

[193] Januchowski R,Sterzyńska K,Nowicki M.Increased expression of several collagen genes is associated with drug resistance in ovarian cancer cell lines..J Cancer2016;7:1295-310 PMCID:PMC4934038

[194] Doessing S,Holm L,Schjerling P.Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis..J Physiol2010;588:341-51 PMCID:PMC2821728

[195] An X,Tan T.Regulation of multidrug resistance by microRNAs in anti-cancer therapy..Acta Pharm Sin B2017;7:38-51 PMCID:PMC5237711

[196] Zhang W,Zhang X,Wang H.Autocrine/paracrine human growth hormone-stimulated microRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer..J Biol Chem2015;290:13812-29 PMCID:PMC4447958

[197] Ma Y,Fan YP,Zhao XM.Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis..Oncotarget2016;7:42805-25 PMCID:PMC5173173

[198] Hao P.Functional roles of sex-biased, growth hormone-regulated microRNAs miR-1948 and miR-802 in young adult mouse liver..Endocrinology2018;159:1377-92 PMCID:PMC5839735

[199] Wang D,Shao Y.microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer..Biosci Rep2017;37: PMCID:PMC5350603

[200] Rodriguez-Antona C.Cytochrome P450 pharmacogenetics and cancer..Oncogene2006;25:1679-91

[201] Bruno RD.Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development..Bioorg Med Chem2007;15:5047-60 PMCID:PMC1958998

[202] Waxman DJ,Pampori NA.Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate..Mol Pharmacol1995;48:790-7

[203] Cheung NW,Coverdale S,Boyages SC.Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man..J Clin Endocrinol Metab1996;81:1999-2001

[204] Gil Berglund E,Beck O,Rane A.Growth hormone replacement therapy induces codeine clearance..Eur J Clin Invest2002;32:507-12

[205] Bhatt AP,Bultman SJ.The role of the microbiome in cancer development and therapy..CA Cancer J Clin2017;67:326-44 PMCID:PMC5530583

[206] Pouncey AL,Alexander JL,Kinross J.Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment..Ecancermedicalscience2018;12:868 PMCID:PMC6145523

[207] Fessler JL.The microbiota: a new variable impacting cancer treatment outcomes..Clin Cancer Res2017;23:3229-31 PMCID:PMC5627769

[208] De Almeida CV,Russo E.Role of diet and gut microbiota on colorectal cancer immunomodulation..World J Gastroenterol2018;25:151-62 PMCID:PMC6337022

[209] Rea D,Palma G,Luciano A.Microbiota effects on cancer: from risks to therapies..Oncotarget2018;9: PMCID:PMC5915165

[210] Yan J.Gut Microbiota and IGF-1..Calcif Tissue Int2018;102:406-14 PMCID:PMC6132071

[211] Friend KE.Cancer and the potential place for growth hormone receptor antagonist therapy..Growth Horm IGF Res2001;11:S121-3

[212] Leporati P,de Martinis L,Magri F.A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression..BMC Cancer2015;15:397 PMCID:PMC4436112

[213] Telleria CM.Drug repurposing for cancer therapy..J Cancer Sci Ther2012;4:ix-xi PMCID:PMC3440183

[214] Langdon CG,Means RE,Mamillapalli R.Combinatorial screening of pancreatic adenocarcinoma reveals sensitivity to drug combinations including bromodomain inhibitor plus neddylation inhibitor..Mol Cancer Ther2017;16:1041-53 PMCID:PMC5457712

[215] Nosengo N.Can you teach old drugs new tricks?.Nature2016;534:314-6

[216] Wu XY,Yao XQ,Xu Z.Growth hormone protects colorectal cancer cells from radiation by improving the ability of DNA damage repair..Mol Med Rep2014;10:486-90